3

21 2015,

60
:
:
: , 3
, 4
, :
,
,
,
, ,

/
( )

, ,

(
)

:
2 (

Glimeperide tabl. 3mg x 1, Metformin

5)

tabl. 850mg x 2 Amlodipine tabl. 10mg x 2

( 3)

Sertraline tabl. 100mg x 1

( 6)
(1 , 24 , PYS 24), 5-6 /.
( , )

:
53

..

Proband

()

:
:


,

:
,

,

:

()

-

-
-

-

Hiatt WR, Goldstone J, Smith SC, Jr., et al. Atherosclerotic Peripheral Vascular Disease
Symposium II: nomenclature for vascular diseases. Circulation 2008;118(25):2826-9.

20 50%
:

10
35%
,

40
50%

>14, ,

5 10%
1% 2%
25% 1

5 Ps

Pain
Pulselessness
Pallor

Paresthesias

Paralysis
,
ACC/AHA Guidelines on the Management of Patients With
Peripheral Arterial
&Disease,
Polar, the
6th p

The PAD Coalition, 2011

Treatment Strategies for Patients With Peripheral Artery Disease (PAD), Agency for Healthcare
Quality
AHRQ,
2013
The Task Force on the Diagnosis and Treatment of Peripheral Artery Research
Diseases and
of the
European
Society

( )

(>50 , 7075 )

,

>70

CRP
WBC
fibrinogen
interleukin-6

Treatment Strategies for Patients With Peripheral Artery Disease (PAD), Agency for Healthcare
Quality
AHRQ,
2013
The Task Force on the Diagnosis and Treatment of Peripheral Artery Research
Diseases and
of the
European
Society

< 50

50 69

1 :

(.
)

70

,
,

,
,
,

The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society

,
/

The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the

(, , )?
()? ?
?
(200m)?
(10)?
,
?
ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial


80-90%

>90%

1.
?

* ,

2. ?
3.
?
4.
?

5. /?
- >10

- 10

Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the
6.

?
WHO/Rose
Questionnaire
for use in epidemiological surveys. J Clin Epidemiol 1992



(standard examination)

:

,

,

The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the
European Society of Cardiology ESC 2011



(standard examination)
:
0 - (absent)
1 -
(diminished)
2 -
(normal)

3 -
(bounding)

ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial

Disease, The PAD Coalition, 2011

ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial
Disease, The PAD Coalition, 2011


Ankle-and
Toes Brachial Indices, segmental pressure
--

examination
Pulse volume recording
Continuous wave doppler ultrasound
6
6

Treadmill exercise testing with and without ABI assessments

and

6min walk test

Duplex ultrasound
Computed tomographic angiography
Magnetic resonance angiography
Contrast angiography
Hirsh et al ACC/AHA Guidelines, Circulation 2006; 113(11): e463-654

()
10 12cm

5 10 MHz Doppler

The Task Force on the Diagnosis

and Treatment of Peripheral Artery Diseases of the
Society
of Cardiology
ESC
Lijmer JG. Ultrasound Med Biol 1996; Feigelson HS. Am J Epidemiol European
1994, Baker
JD. Surgery
1981; Ouriel
K.2011
Arch

()

:
0,80 0,90 .. 3 (>95%
)
1,10 1,00 .. 3 (>99%
)

PAP test

30 - 87

86 100

37 - 78

87 98

75 - 90

90 95

95

100

Belch JJ et al, Arch Intern Med, 2003, Nanda et al Ann Intern Med 2000, Allison et al New Eng J Med
1996, Ferrini et al Ame J Prev Med 1996, Dormandy et al Semin Vasc Surg 1999, Fowkes et al

< 0.90 0,15

0.91

0.99

1.00

1.40

< 0.5

0.4

(
)

0.4
0.0 0.5

0.7

0.
9

0.99
1.0

>
1.4

ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial

Disease,
The PAD
2011
Aboyans
V etCoalition,
al, Circulation



Fontaine

<
mapping
>

IIa
IIb
III
IV

>
200m
-

<
200m

Rutherford

1
2
3

4
5
6

()

, ,

178cm, 91kg, BMI = 28,72

120cm, 110cm, : 1,09

155/80mmHg, 65/min
,

Glu 140mg/dl , Glu 3

0,57
Fontaine II a
Rutherford 1

-, ,


,
, , :
, , ,
, (varenicline, bupropion,
),

:
30 50 min, 3 5 ,
> 12
180% , 120%

:
, (.. ,
, )
ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial




HMG coenzyme-A reductase inhibitor (statin):
, LDL cholesterol <100 mg/dl,
<70mg/dl

:
, <140/90mmHg
<130/80mm/Hg ( , )
, , ,

:
, HbA1C 7.0%,
70130mg/dl, 180 mg/dL
ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial
Disease,
The PAD
Coalition,2014
2011
Standards of Medical Care in Diabetes, American
Diabetes
Association

<

0.90
0.91 0.99

Aspirin
Clopidogrel

75-325 mg/

75 mg/

Aspirin + Clopidogrel

,
,

(
)

CHARISMA, dual therapy vs

Aspirin)

Pentoxifylline
(Tarontal)

75-100mg/ Aspirin
Ticagrelor (Brilique)

Cilotazol (Cilostazol)

Aspirin,
Aspirin.
Clopidogrel,
Clopidogrel

,
?
Naftidrofuryl

(Praxilene)

ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial Disease, The
Treatment Strategies for Patients With Peripheral Artery Disease (PAD), Agency for Healthcare
Research2011
and
PAD Coalition,

 NOVEL

Factor Xa

Apixaban (Eliquis)
Rivaroxaban (Xarelto)
Otamixaban
Betrixaban
Edoxaban

Dabigatran etexilate
(Pradaxa)
Ximelagatran (Exanta)
Argatroban

SSRIs, SNRIs, NSAIDs

Aspirin + Rivaroxaban
WAVE (+)

! ,
Novel anticoagulants in the therapy of peripheral arterial and coronary artery disease

Vincenzo Jacomella et al, Current Opinion in Pharmacology 2013, 13:17

< 0.9

()

3-

(Cilostazol,
Pentoxifylline)

3-

< 0.4

ACC/AHA Guidelines on the Management of Patients With Peripheral Arterial

21 2015,